FENU, SANDRO
 Distribuzione geografica
Continente #
EU - Europa 125.084
NA - Nord America 8.337
AS - Asia 3.277
SA - Sud America 555
Continente sconosciuto - Info sul continente non disponibili 235
AF - Africa 54
OC - Oceania 5
Totale 137.547
Nazione #
IT - Italia 122.779
US - Stati Uniti d'America 8.207
SG - Singapore 1.321
CN - Cina 1.170
UA - Ucraina 705
BR - Brasile 452
SE - Svezia 405
DE - Germania 381
VN - Vietnam 272
FI - Finlandia 254
GB - Regno Unito 212
FR - Francia 177
HK - Hong Kong 124
KR - Corea 90
CA - Canada 77
IN - India 73
RU - Federazione Russa 51
BD - Bangladesh 35
AR - Argentina 33
EC - Ecuador 24
IQ - Iraq 23
TR - Turchia 23
JP - Giappone 22
MX - Messico 21
ES - Italia 18
BE - Belgio 17
PK - Pakistan 17
PL - Polonia 16
CO - Colombia 15
ZA - Sudafrica 14
JM - Giamaica 12
NL - Olanda 12
ID - Indonesia 11
IR - Iran 10
UZ - Uzbekistan 10
IE - Irlanda 9
MA - Marocco 9
PH - Filippine 9
EU - Europa 8
VE - Venezuela 8
SA - Arabia Saudita 7
AZ - Azerbaigian 6
DZ - Algeria 6
EG - Egitto 6
IL - Israele 6
KE - Kenya 6
UY - Uruguay 6
AL - Albania 5
CL - Cile 5
CR - Costa Rica 5
CZ - Repubblica Ceca 5
JO - Giordania 5
RO - Romania 5
TN - Tunisia 5
AU - Australia 4
BO - Bolivia 4
OM - Oman 4
PY - Paraguay 4
TT - Trinidad e Tobago 4
TW - Taiwan 4
AE - Emirati Arabi Uniti 3
AT - Austria 3
BG - Bulgaria 3
BN - Brunei Darussalam 3
CH - Svizzera 3
LT - Lituania 3
MD - Moldavia 3
MY - Malesia 3
NP - Nepal 3
PE - Perù 3
PS - Palestinian Territory 3
SK - Slovacchia (Repubblica Slovacca) 3
TH - Thailandia 3
BB - Barbados 2
BY - Bielorussia 2
CY - Cipro 2
GR - Grecia 2
GT - Guatemala 2
HU - Ungheria 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LB - Libano 2
LK - Sri Lanka 2
MN - Mongolia 2
NO - Norvegia 2
PA - Panama 2
PT - Portogallo 2
RS - Serbia 2
SN - Senegal 2
SY - Repubblica araba siriana 2
AO - Angola 1
BW - Botswana 1
CI - Costa d'Avorio 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
IS - Islanda 1
LA - Repubblica Popolare Democratica del Laos 1
Totale 137.311
Città #
Cagliari 120.469
Uta 1.951
Fairfield 765
Woodbridge 712
Singapore 663
Ashburn 647
Chandler 561
San Jose 474
Houston 438
Ann Arbor 406
Jacksonville 381
Boardman 374
Dallas 365
Wilmington 354
Seattle 309
Nyköping 272
Cambridge 248
Beijing 190
Dearborn 157
Helsinki 146
Los Angeles 135
Santa Clara 118
Nanjing 117
Council Bluffs 111
Hong Kong 108
Lauterbourg 101
Ho Chi Minh City 96
Hefei 94
Boston 89
Seoul 88
The Dalles 82
Shanghai 79
Buffalo 69
Hanoi 63
New York 60
Milan 51
Guangzhou 45
San Diego 41
São Paulo 39
Shenyang 38
Toronto 38
Nanchang 32
Hebei 30
Redwood City 30
Changsha 27
Jiaxing 27
Tianjin 27
Norwalk 26
Verona 25
Orem 19
Frankfurt am Main 18
Chicago 17
Mountain View 17
Brussels 16
London 15
Washington 15
Auburn Hills 14
Montreal 14
Munich 14
Redondo Beach 14
Tokyo 14
Brasília 13
Chennai 13
Kunming 13
Orange 13
Augusta 12
Upgant-schott 12
Zhengzhou 12
Hangzhou 11
Ningbo 11
Atlanta 10
Columbus 10
Jinan 10
Rio de Janeiro 10
Brooklyn 9
Curitiba 9
Da Nang 9
Kingston 9
Mumbai 9
Rome 9
San Mateo 9
Tashkent 9
Campinas 8
Guarulhos 8
Haiphong 8
Istanbul 8
Quito 8
Saint Petersburg 8
San Francisco 8
Ardabil 7
Belo Horizonte 7
Biên Hòa 7
Juiz de Fora 7
Mexico City 7
Naples 7
New Delhi 7
Salvador 7
Sassari 7
Assèmini 6
Baghdad 6
Totale 132.308
Nome #
Acquisition and expression of conditioned taste aversion differentially affects extracellular signal regulated kinase and glutamate receptor phosphorylation in rat prefrontal cortex and nucleus accumbens 4.610
null 4.110
Role of nucleus accumbens μ opioid receptors in the effects of morphine on ERK1/2 phosphorylation 4.061
Caffeine and the brain: an overview 3.742
Pharmacological characterization of 50-kHz ultrasonic vocalizations in rats: comparison of the effects of different psychoactive drugs and relevance in drug-induced reward 3.660
Immunomodulatory drugs alleviate l-dopa-induced dyskinesia in a rat model of Parkinson's disease 3.467
Strain dependence of adolescent Cannabis influence on heroin reward and mesolimbic dopamine transmission in adult Lewis and Fischer 344 rats 3.385
Behavioural pharmacology of caffeine 3.217
Evaluation of rewarding properties of pramipexole in a rat model of Parkinson’s disease: role of genetic background 3.094
Neuroinflammation in L-DOPA-induced dyskinesia: beyond the immune function 2.948
Behavioral Pharmacology of Caffeine 2.821
Conditioned saccharin avoidance induced by infusion of amphetamine in the Nucleus Accumbens shell and morphine in the Ventral Tegmental Area: behavioral and biochemical study 2.728
L dopa chronic treatment increases reactive microglia and tnf- alpha production in the 6-ohda lesioned striatum 2.713
In vivo dopamine agonist properties of rotigotine: Role of D1 and D2 receptors 2.682
Conditioned saccharin avoidance induced by infusion of amphetamine in the Nucleus Accumbens shell and morphine in the Ventral Tegmental Area: a behavioral and biochemical study 2.563
Disease modifying treatment with PPAR-gamma agonist rosiglitazone in a progressive mouse model of Parkinson's disease 2.502
Adolescent Cannabis exposure differentially affects heroin reinforcement and accumbens dopamine transmission in Lewis and Fischer344 rats 2.475
Possibile ruolo dei recettori 5-HT6 nelle dipendenze 2.263
null 2.160
null 2.148
Conditioned Saccharine Avoidance induced by intra-Accumbens shell amphetamine and intra-VTA morphine 2.140
Conditioned Saccharine Avoidance induced by infusion of amphetamine in the Nucleus Accumbens shell and morphine in the Ventral Tegmental Area 2.127
Behavioral and neurochemical pharmacology of 5-HT6 receptors related to reward and reinforcement 2.099
Influence of strain and age on voluntarily ethanol intake and on GAD-67 expression in the central amygdala 2.088
Morphine-conditioned single-trial place preference: role of nucleus accumbens shell dopamine receptors in acquisition, but not expression 2.043
Possibile ruolo dei recettori 5-HT6 nelle dipendenze - Possible role of 5-HT6 receptors in addictions 2.021
null 1.797
Pharmacological therapy of Parkinson's disease: current options and new avenues 1.786
Effect of adenosine A1 and A2A antagonists on 3,4 methylenedioxymethamphetamine (MDMA)-induced neuroinflammation and dopamine neuron toxicity in mouse brain 1.755
Nicotine-conditioned single-trial place preference: selective role of nucleus accumbens shell dopamine D1 receptors in acquisition 1.743
Caffeine potentiation of 3,4-methylenedioxymethamphetamine (MDMA) toxicity: role of age 1.641
Reinforcing, rewarding and dopamine-stimulant properties of the 5-HT6 receptor agonist ST1936: the first member of a new class of psychostimulant? 1.600
null 1.580
REINFORCING, REWARDING AND DOPAMINE-STIMULANT PROPERTIES OF THE 5-HT6 RECEPTOR AGONIST ST1936: THE FIST MEMBER OF A NEW CLASS OF PSYCHOSTIMULANTS? 1.575
Controversie: Priming dopaminergico nel Parkinson. Il "priming" come modello sperimentale delle discinesie indotte da terapie dopaminergiche sostitutive nella Malattia di Parkinson 1.532
Blockade of globus pallidus adenosine A2A receptors displays antiparkinsonian activity in 6-hydroxydopamine-lesioned rats treated with D1 or D2 dopamine receptor agonists 1.302
Effects of QO-IIR, a new COMT inhibitor, in experimental animal models of parkinson’s disease: behavioural, neurochemical and immunoistochemical study 1.271
Caffeine potentiates 3,4 methylenedioxymethamphetamine (MDMA, ecstasy)-induced-glial activation: role of age and adenosine A1 and A2A receptors 1.104
Differential involvement of dopamine D1 receptors in morphine- and lithium- conditioned saccharin avoidance 1.095
Impulse control disorders and dopamine dysregulation syndrome associated with dopamine agonist therapy in Parkinson's disease 1.029
Role of Adenosine A1 and A2A receptors on 3,4-methylendioxymeth-amphetamine (MDMA, Ecstasy)-induced neurotoxicity, astroglia and microglia reactivity in mouse striatum and substantia nigra 1.010
Differential effect of MK 801 and scopolamine on c-fos expression induced by L-dopa in the striatum of 6-hydroxydopamine lesioned rats 974
Selective modifications in GAD67 mRNA levels in striatonigral and striatopallidal pathways correlate to dopamine agonist priming in 6-hydroxydopamine-lesioned rats 934
A role for dopamine D1 receptors of the nucleus accumbens shell in conditioned taste aversion learning 920
Differential induction of dyskinesia and neuroinflammation by pulsatile versus continuous L-DOPA delivery in the 6-OHDA model of Parkinson's disease 841
Alterations in GAD67, dynorphin and enkephalin mRNA in striatal output neurons following priming in the 6-OHDA model of Parkinson’s disease 840
Blockade of muscarinic receptors potentiates D1 dependent turning behavior and c-fos expression in 6-hydroxydopamine-lesioned rats but does not influence D2 mediated responses 818
null 801
Modulation of dopamine d1-mediated turning behavior and striatal c-fos expression by the substantia nigra 798
Effect of MK 801 on priming of D-1-dependent contralateral turning and its relationship to c-fos expression in the rat caudate-putamen 776
Conditioned saccharin avoidance and sensitization to drugs of abuse 769
Accumbens shell dopamine and stimulus-reward learning 765
“Priming” to dopamine agonist-induced contralateral turning as model of non associative sensitization to the expression of the post-synaptic dopamine message 765
Effetto del blocco dei recettori oppioidi delta sul turning controlaterale indotto dagli agonisti dopaminergici in ratti lesionati con la 6-idrossidopamina 720
Dopamine and drug addiction: the nucleus accumbens shell connection 701
Influence of Age and Genetic Background on Ethanol Intake and Behavioral Response Following Ethanol Consumption and During Abstinence in a Model of Alcohol Abuse 701
Behavioural expression of D-1 receptor supersensitivity depends on previous stimulation of D-2 receptors 693
Conditioned saccharin avoidance and sensitization to drugs of abuse 672
Blockade of pallidal adenosine A2A receptors potentiates contralateral rotational behavior induced by L-DOPA and dopaminergic agonists in hemiparkinsonian rats 656
Changes in GAD67 and peptides mRNA levels in specific populations of striatal efferent neurons following priming with dopamine agonists in 6-OHDA lesioned rats 651
Adenosine A2 Receptors interact negatively with dopamine D1 and D2 receptors in unilaterally 6-hydroxydopamine-lesioned rats 647
Time and dose dependence of the 'priming' of the expression of dopamine receptor supersensitivity. 637
Positive and negative interactions in the behavioural expression of D1 and D2 receptor stimulation in a model of parkinsonism: role of priming 636
Alterazioni nei livelli striatali di RNAm della GAD67, dinorfina e enkefalina, in seguito a priming con agonisti dopaminergici nel modello di morbo di parkinson della 6-ohda 636
Different involvement of Dopamine D1 receptor in morphine and lithium conditioned saccharin avoidance 635
 and  opiate receptors mediate specific behavioral syndromes from the Substantia Nigra. 632
Blockade of n-methyl-d-aspartate receptors potentiates dopaminergic responses in the 6-ohda model of parkinson: differential role of D1 and D2 receptors 625
Differential effect of priming with dopamine agonists on mrna for GAD-67, dynorphin and enkephalin in 6-OHDA lesioned rats 620
Effect of delta opioid receptors blockade on turning behavior induced by dopamine agonists in unilaterally 6-hydroxydopamine lesioned rats 612
Substantia nigra as a site of origin of dopamine-dependent motor syndromes induced by stimulation of mu and delta opioid receptors. 595
null 594
null 580
‘Priming’ phenomena in the expression of D1 and D2 receptor supersensitivity 579
Different involvement of dopamine D1 receptor in morphine- and lithium-induced conditioned saccharin avoidance 565
Opposite effects of nmda receptor blockade on dopaminergic d1-mediated and d2-mediated behavior in the 6-hydroxydopamine model of turning - relationship with c-fos expression 558
Differential role of dopamine in drug- and lithium conditioned saccharin avoidance 558
CONDITIONED TASTE AVERSION ELICITED ERK ACTIVATION AND CHANGES OF DENDRITIC SPINES DENSITY: AN IMMUNOHISTOCHEMICAL, GOLGI-COX AND ELECTRON MICROSCOPY STUDY 546
Blockade of n-methyl-d-aspartate receptors potentiates dopaminergic responses in the 6-ohda model of parkinson: differential role of D1 and D2 receptors 540
Opposite effects of NMDA receptor blockade on dopaminergic D1 and D2-mediated behavior in the 6-hydroxydopamine model of turning: relationship with c-fos expression 531
Modulation of turning behavior induced by dopamine D1 agonists in 6-hydroxydopamine lesioned rats by intranigral infusion of glutamate antagonists. 527
Modulation of Delta(9)-THC-induced increase of cortical and hippocampal acetylcholine release by micro opioid and D(1) dopamine receptors 521
null 515
null 504
The influence of priming on the behavioral expression of dopamine receptor supersensitivity in basal ganglia 485
null 479
Priming of the behavioral expression of dopamine-receptor supersensitivity in the basal ganglia: pharmacological and biochemical studies 452
Nicotine-conditioned single–trial place preference: selective role of nucleus accumbens shell dopamine D1 receptors in acquisition 450
Differential role of dopamine in drug- and lithium-conditioned saccharin avoidance 438
Priming of the behavioral of dopamine-receptor supersensitivity in the basal ganglia: pharmacological and biochemical studies 435
Blockade of NMDA receptors differentially affects D1 and D2 mediated turning behavior in the 6-hydroxydopamine model of Parkinson 431
null 425
Cross-sensitization between the motor activating effects of bromocriptine and caffeine: role of adenosine A2A receptors 422
Dissociation of dopamine D1-induced turning behaviour and D1-induced increases in striatal acetylcholine release in 6-OHDA lesioned rats 409
Ruolo dell’acetilcolina striatale sul turning indotto dagli agonisti dopaminergici D1 in un modello sperimentale di morbo di parkinson: studio combinato microdialisi/comportamento. 400
Motor stimulant effects of caffeine in 6-hydroxydopamine lesioned rats are dependent on previous stimulation of dopamine receptors: a different role of D1 and D2 receptors 399
Facilitation of conditioned taste aversion learning by systemic amphetamine: role of nucleus accumbens shell dopamine D1 receptors 388
Adenosine A2A receptor antagonism potentiates L-DOPA-induced turning behaviour and c-fos expression in 6-hydroxydopamine-lesioned rats 382
Dopamine and adenosine receptor interaction as basis for the treatment of Parkinson's disease 368
Involvement of globus pallidus in the antiparkinsonian effects of adenosine A2A receptor antagonists 355
Drug addiction as a disorder of associative learning. Role of nucleus accumbens shell/extended amygdala dopamine 355
Totale 130.948
Categoria #
all - tutte 180.941
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 180.941


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224.625 0 488 276 417 493 326 251 265 507 566 547 489
2022/20237.785 624 961 1.037 665 565 767 427 687 556 582 632 282
2023/202410.460 502 1.523 597 805 999 1.433 1.135 834 369 660 791 812
2024/202511.108 1.242 1.904 2.184 1.535 976 1.042 1.115 122 262 265 202 259
2025/20265.569 304 235 707 486 341 351 1.405 321 363 585 358 113
2026/2027264 108 156 0 0 0 0 0 0 0 0 0 0
Totale 137.547